CN1327856C - Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process - Google Patents
Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process Download PDFInfo
- Publication number
- CN1327856C CN1327856C CNB2003101139441A CN200310113944A CN1327856C CN 1327856 C CN1327856 C CN 1327856C CN B2003101139441 A CNB2003101139441 A CN B2003101139441A CN 200310113944 A CN200310113944 A CN 200310113944A CN 1327856 C CN1327856 C CN 1327856C
- Authority
- CN
- China
- Prior art keywords
- injection
- water
- alcohol
- freeze
- effective site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002347 injection Methods 0.000 title claims abstract description 46
- 239000007924 injection Substances 0.000 title claims abstract description 46
- 239000000843 powder Substances 0.000 title claims abstract description 26
- 241001061264 Astragalus Species 0.000 title claims description 11
- 235000006533 astragalus Nutrition 0.000 title claims description 11
- 238000000034 method Methods 0.000 title abstract description 5
- 238000005728 strengthening Methods 0.000 title abstract 4
- 210000004233 talus Anatomy 0.000 title description 4
- 241000208340 Araliaceae Species 0.000 title 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title 1
- 235000003140 Panax quinquefolius Nutrition 0.000 title 1
- 235000008434 ginseng Nutrition 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 123
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 52
- 238000000605 extraction Methods 0.000 claims abstract description 33
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract 5
- 150000004676 glycans Chemical class 0.000 claims description 38
- 229920001282 polysaccharide Polymers 0.000 claims description 38
- 239000005017 polysaccharide Substances 0.000 claims description 38
- 239000000706 filtrate Substances 0.000 claims description 31
- 241000756943 Codonopsis Species 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 22
- 230000006837 decompression Effects 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 16
- 239000002244 precipitate Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 9
- 229930195725 Mannitol Natural products 0.000 claims description 9
- 239000000594 mannitol Substances 0.000 claims description 9
- 235000010355 mannitol Nutrition 0.000 claims description 9
- 238000001556 precipitation Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims description 7
- 239000012510 hollow fiber Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 239000008215 water for injection Substances 0.000 claims description 7
- -1 filters Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 238000002242 deionisation method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 238000002203 pretreatment Methods 0.000 claims description 2
- 239000000284 extract Substances 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 abstract description 2
- 238000003809 water extraction Methods 0.000 abstract description 2
- 238000004108 freeze drying Methods 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000008687 shenqi fuzheng Substances 0.000 description 28
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 230000000242 pagocytic effect Effects 0.000 description 5
- 241000545442 Radix Species 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 210000003024 peritoneal macrophage Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Group | Dosage (mg/kg) | Thymus index (mg/g) | Index and spleen index (mg/g) |
Contrast | - | 17.544±2.98 | 48.30±7.35 |
Injection SHENQI FUZHENG freeze-dried powder | 200 | 21.365±5.12 * | 131.25± 14.23 *** |
Positive control (SHENQI FUZHENG ZHUSHEYE) | 200 | 17.891±3.05 | 121.23± 16.45 *** |
Group | Dosage (mg/kg) | Phagocytic index | Phagocytic percentage (%) |
Matched group | 0.000±0.000 | 0.00±0.00 | |
Injection SHENQI FUZHENG freeze-dried powder | 200 | 5.02±3.12 ** | 0.263± 0.157 * |
Positive control (SHENQI FUZHENG ZHUSHEYE) | 200 | 0.73±0.61 * | 0.013± 0.010 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101139441A CN1327856C (en) | 2003-11-07 | 2003-11-07 | Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101139441A CN1327856C (en) | 2003-11-07 | 2003-11-07 | Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1541699A CN1541699A (en) | 2004-11-03 |
CN1327856C true CN1327856C (en) | 2007-07-25 |
Family
ID=34336994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101139441A Expired - Lifetime CN1327856C (en) | 2003-11-07 | 2003-11-07 | Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1327856C (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1320920C (en) * | 2005-01-21 | 2007-06-13 | 邹巧根 | Freeze-dried powder injection of glossy privet fruit and astragalus root for strengthening body resistance and its making method |
CN1320921C (en) * | 2005-01-21 | 2007-06-13 | 邹巧根 | Small injection of glossy privet fruit and astragalus root and its making method |
CN1311864C (en) * | 2005-01-21 | 2007-04-25 | 邹巧根 | Infusion liquid of glossy privet fruit and astragalus root for strengthening body resistance and its making method |
CN1320896C (en) * | 2005-04-13 | 2007-06-13 | 丽珠集团利民制药厂 | Dangshen astragalus composition for regulating immunity and its preparation method |
CN100349579C (en) * | 2005-11-18 | 2007-11-21 | 广东大光药业有限公司 | Composition of ginseng-astragalus polysaccharides and its preparing method |
CN100417396C (en) * | 2006-03-14 | 2008-09-10 | 北京国丹药物技术开发有限公司 | Preparing method of body resistance-strengthening ginseng-astragalus injection |
CN101084979B (en) * | 2006-06-08 | 2012-02-01 | 天津天士力之骄药业有限公司 | Medicinal preparation for cancer auxiliary treatment and its preparation method |
CN109939136A (en) * | 2017-12-21 | 2019-06-28 | 北京盈科瑞创新药物研究有限公司 | A kind of sucking body resistance-strengthening ginseng-astragalus pharmaceutical solutions and preparation method thereof |
CN113599412A (en) * | 2021-03-10 | 2021-11-05 | 丽珠集团利民制药厂 | Application of radix codonopsis and radix astragali composition in preparation of medicine for preventing and treating symptoms related to advanced tumor |
-
2003
- 2003-11-07 CN CNB2003101139441A patent/CN1327856C/en not_active Expired - Lifetime
Non-Patent Citations (7)
Title |
---|
临床疗效观察 中国中西医结合杂志,第18卷第11期 1998 * |
临床疗效观察 中国中西医结合杂志,第19卷第1期 1999 * |
党参提取物对小鼠中枢神经系统的药理作用 潘思源等,中草药,第18卷第7期 1987 * |
党参的抗缺氧作用 王开贞等,中药通报,第11卷第8期 1986 * |
常用补益中药抗脂质过氧化作用比较 裘月等,中国药学杂志,第31卷第2期 1996 * |
常用补益中药抗脂质过氧化作用比较 裘月等,中国药学杂志,第31卷第2期 1996;党参的抗缺氧作用 王开贞等,中药通报,第11卷第8期 1986;党参提取物对小鼠中枢神经系统的药理作用 潘思源等,中草药,第18卷第7期 1987;临床疗效观察 中国中西医结合杂志,第18卷第11期 1998;临床疗效观察 中国中西医结合杂志,第19卷第1期 1999;用化学发光法检测丹参、红藤、当归、黄芪等中药制剂的抗自由基作用 胡天喜等,上海中医药杂志,第9期 1988 * |
用化学发光法检测丹参、红藤、当归、黄芪等中药制剂的抗自由基作用 胡天喜等,上海中医药杂志,第9期 1988 * |
Also Published As
Publication number | Publication date |
---|---|
CN1541699A (en) | 2004-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101020719B (en) | Composite angelica polysaccharide and its preparation process and use | |
CN1327856C (en) | Freeze-dried qi-strengthening ginseng and astragalus powder for injection and its preparing process | |
CN101375990A (en) | Composition for treating cardiovascular disease and preparation thereof | |
CN1264529C (en) | Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process | |
CN1788758A (en) | Use of traditional Chinese medicine garden burnet and its extract in preparing drug for raising red cell and blood hemoglobin | |
CN1883566A (en) | Anti-inflammation medicine and method for preparing same | |
CN106913858B (en) | Application of eucheuma polypeptide in preventing and treating pulmonary fibrosis | |
CN1264530C (en) | Freeze-dried 'Shenqifuzheng' powder for injection and its preparing process | |
CN102225089B (en) | Pharmaceutical composition for treating cancers, pharmaceutical preparation as well as applications and production methods thereof | |
CN1695686A (en) | Injection preparation of 'Zhenqi' inuse for strengthening the body resistance, and preparation method | |
CN101357213B (en) | Compound cantharis liquid formulation and preparation method thereof | |
CN101357212B (en) | Compound cantharis injection and preparation method thereof | |
CN102716231B (en) | A kind of Chinese medicine composition and application thereof for the treatment of brain injury and cerebral edema | |
CN101176750A (en) | Chaihuang freeze dried injection and preparation method thereof | |
CN1850097A (en) | Scutellarin injection preparation and its preparing method | |
CN1836684A (en) | Silktree albizzia general saponin and its extraction method, pharmaceutical use of the said composition and medicine preparation | |
CN1557403A (en) | Medicine for treating angiocardiopathy and cerebrovascular disease and its preparing method | |
CN100387236C (en) | Pharmacetutical for treating cardiovascular and cerebrovascular disease and its preparing process | |
CN101167784A (en) | Medicinal composition for cardiovascular and cerebrovascular diseases | |
CN100551404C (en) | Medicament for inducing diuresis to alleviate edema preparation of compositions and detection method and purposes | |
CN101468060A (en) | Pharmaceutical composition | |
CN105687567A (en) | Preparation for preventing and treating diarrhea caused by chemotherapy and preparation method of preparation | |
CN1899352A (en) | Chinese medicine effective part composition for supplementing qi and recovering pulse | |
CN1256083C (en) | Medicine for boosting qi and nourishing blood and its prepatation method | |
CN100484560C (en) | Sarcandra powder injection and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TASLY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHANG QINGLONG Effective date: 20050415 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050415 Address after: 300402 Beichen science and Technology Park, Tianjin Applicant after: TIANJIN TASLY PHARMACEUTICAL Co.,Ltd. Address before: 510610 Guangdong city of Guangzhou province forest and Road No. 150, Room 802 on the eighth floor of Tianyu Garden Plaza Accord Applicant before: Zhang Qinglong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Beichen science and Technology Park, Tianjin Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300402 Beichen science and Technology Park, Tianjin Patentee before: TIANJIN TASLY PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Beichen science and Technology Park, Tianjin Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300402 Beichen science and Technology Park, Tianjin Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CX01 | Expiry of patent term |
Granted publication date: 20070725 |
|
CX01 | Expiry of patent term |